Publications by authors named "Erika Toyokura"

Background: Physical activity is one of the most important prognostic factors for patients with chronic obstructive pulmonary disease (COPD). Physical activity correlates significantly with skeletal muscle mass and strength. Pulmonary rehabilitation has been conducted to improve physical activity, but its effectiveness has been inconsistent.

View Article and Find Full Text PDF
Article Synopsis
  • Bronchial thermoplasty (BT) is a treatment for severe asthma, but the asthma types that respond well to it aren't fully clarified.
  • A study in Japan revealed significant improvements in asthma quality of life, reduced corticosteroid use, and fewer exacerbations after BT, but lung function remained unchanged.
  • Overweight or obese patients with uncontrolled severe asthma benefited more from BT compared to those with normal weight, highlighting the potential advantages of this treatment for certain patient profiles.
View Article and Find Full Text PDF

Insufficient evidence has been accumulated regarding associations of heated tobacco products (HTPs) use with coronavirus infection and severity of coronavirus disease 2019 (COVID-19), an ongoing pandemic. We conducted a cross-sectional study using data from an internet questionnaire administered in February 2022 to 30,130 individuals from the general Japanese population (age range, 16-81 years). Single users of HTPs and dual users of combustible cigarettes and HTPs comprised 5.

View Article and Find Full Text PDF

Background: This study investigated the effect of adjuvant sublingual immunotherapy (SLIT) on inhaled corticosteroid (ICS) dose in patients with pollinosis-associated asthma.

Methods: We retrospectively evaluated patients with cedar pollinosis-associated asthma who initiated pharmacotherapy with or without adjuvant SLIT therapy from December 2014 to December 2016 and who continued treatment for 3 years. Changes in ICS dose (fluticasone propionate or its equivalent), antihistamine use, leukotriene antagonist use and intranasal corticosteroid (INCS) use over the 3-year period were compared.

View Article and Find Full Text PDF